Neoplasms, Colorectal Completed Phase 2 Trials for Leucovorin (DB00650)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00967616Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line TherapyTreatment
NCT02246049A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRCTreatment
NCT01289821First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With RegorafenibTreatment
NCT00615056A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line RegimenTreatment
NCT00851084Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal CancerTreatment
NCT01765582A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Participants With Metastatic Colorectal Cancer (STEAM)Treatment